Table 1.
Sample sizes of GWASs used in this study
| OA phenotype | Affected individuals | Control individuals | Total |
|---|---|---|---|
| All | 177,517 | 649,173 | 826,690 |
| Knee | 62,497 | 333,557 | 396,054 |
| Knee and/or hip | 89,741 | 400,604 | 490,345 |
| Hip | 36,445 | 316,943 | 353,388 |
| TKR | 18,200 | 233,841 | 252,041 |
| TJR | 40,887 | 327,689 | 368,576 |
| THR | 23,021 | 296,016 | 319,037 |
An overview of the osteoarthritis (OA) phenotypes used in this work and the number of affected individuals, control individuals, and total number of individuals included in the corresponding GWAS (total knee replacement [TKR], total hip replacement [THR], total joint replacement [TJR], and osteoarthritis at any site [all]).